{"id":8467,"date":"2025-11-18T18:00:32","date_gmt":"2025-11-18T17:00:32","guid":{"rendered":"https:\/\/hemerion.com\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\/"},"modified":"2025-11-18T18:00:37","modified_gmt":"2025-11-18T17:00:37","slug":"hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance","status":"publish","type":"post","link":"https:\/\/hemerion.com\/fr\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\/","title":{"rendered":"Hemerion ouvre un nouveau site d\u2019investigation en Europe et acc\u00e9l\u00e8re le d\u00e9veloppement clinique de la th\u00e9rapie combin\u00e9e Pentalafen \/ Heliance"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>A la suite du lancement de sa derni\u00e8re \u00e9tude clinique aux USA, Hemerion a obtenu l\u2019autorisation de l\u2019ANSM (Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9) pour ouvrir un nouveau centre d\u2019essai au CHU de Lille en juillet 2025.<\/strong><br\/><strong>Cette ouverture confirme la capacit\u00e9 d\u2019Hemerion \u00e0 travailler efficacement avec les autorit\u00e9s sanitaires de part et d\u2019autre de l\u2019Atlantique : un atout rare pour une healthtech tricolore.<\/strong><br\/><\/p>\n\n<p class=\"wp-block-paragraph\">Ouvert en juillet, le site d\u2019investigation ouvert par Hemerion au CHU de Lille renforce sensiblement les capacit\u00e9s d\u2019inclusion de nouveaux patients pour <a href=\"https:\/\/hemerion.com\/fr\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\/\">l\u2019\u00e9tude clinique HTX-GBM-01 initi\u00e9e par Hemerion aux USA en collaboration avec le University of Pennsylvania Medical Center (UPMC) de Pittsburgh<\/a>.<\/p>\n\n<p class=\"wp-block-paragraph\">Plus grand campus hospitalo-universitaire d&rsquo;Europe, le CHU de Lille est un acteur majeur des essais cliniques en France avec plus de 8000 patients par an.<\/p>\n\n<p class=\"wp-block-paragraph\">L\u2019investigatrice principale est le Dr. Enora Vaul\u00e9on du D\u00e9partement de neuro-oncologie au CHU de Lille. Le site est \u00e9quip\u00e9 des derni\u00e8res versions de la plateforme Heliance\u00ae, qui b\u00e9n\u00e9ficient des am\u00e9liorations notables apport\u00e9es par Hemerion Therapeutics \u00e0 <a href=\"https:\/\/hemerion.com\/fr\/solutions-therapeutiques\/\">sa technologie<\/a> depuis 5 ans. <\/p>\n\n<p class=\"wp-block-paragraph\">L\u2019objectif est double : confirmer les r\u00e9sultats cliniques tr\u00e8s encourageants observ\u00e9s lors des travaux de recherche initiaux men\u00e9s par l&rsquo;Inserm, le CHU de Lille et l&rsquo;Universit\u00e9 de Lille entre 2017 et 2020, et si possible, les am\u00e9liorer gr\u00e2ce aux perfectionnements de la technologie Pentalafen\u00ae \/ Heliance\u00ae.<\/p>\n\n<h2 class=\"gb-headline gb-headline-98c0cf95 gb-headline-text\">Un d\u00e9veloppement clinique men\u00e9 sur 2 continents<\/h2>\n\n<p class=\"wp-block-paragraph\">Cette ouverture de site illustre la capacit\u00e9 d\u2019Hemerion \u00e0 travailler efficacement avec les r\u00e9glementations sanitaires europ\u00e9ennes et am\u00e9ricaines : un atout rare dans le secteur des healthtechs, essentiel pour mener de front les op\u00e9rations \u00e0 venir de market access sur ces deux territoires majeurs.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A la suite du lancement de sa derni\u00e8re \u00e9tude clinique aux USA, Hemerion a obtenu l\u2019autorisation de l\u2019ANSM (Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9) pour ouvrir un nouveau centre d\u2019essai au CHU de Lille en juillet 2025.Cette ouverture confirme la capacit\u00e9 d\u2019Hemerion \u00e0 travailler efficacement avec les autorit\u00e9s sanitaires de &#8230; <\/p>\n<p class=\"read-more-container\"><a title=\"Hemerion ouvre un nouveau site d\u2019investigation en Europe et acc\u00e9l\u00e8re le d\u00e9veloppement clinique de la th\u00e9rapie combin\u00e9e Pentalafen \/ Heliance\" class=\"read-more button\" href=\"https:\/\/hemerion.com\/fr\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\/#more-8467\" aria-label=\"En savoir plus sur Hemerion ouvre un nouveau site d\u2019investigation en Europe et acc\u00e9l\u00e8re le d\u00e9veloppement clinique de la th\u00e9rapie combin\u00e9e Pentalafen \/ Heliance\">Lire plus<\/a><\/p>\n","protected":false},"author":207845439,"featured_media":8466,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_jet_sm_ready_style":"","_jet_sm_style":"","_jet_sm_controls_values":"","_jet_sm_fonts_collection":"","_jet_sm_fonts_links":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[6342],"tags":[],"class_list":["post-8467","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualites"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Hemerion ouvre un nouveau site d\u2019investigation en Europe et acc\u00e9l\u00e8re le d\u00e9veloppement clinique de la th\u00e9rapie combin\u00e9e Pentalafen \/ Heliance - Hemerion<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hemerion.com\/fr\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hemerion ouvre un nouveau site d\u2019investigation en Europe et acc\u00e9l\u00e8re le d\u00e9veloppement clinique de la th\u00e9rapie combin\u00e9e Pentalafen \/ Heliance - Hemerion\" \/>\n<meta property=\"og:description\" content=\"A la suite du lancement de sa derni\u00e8re \u00e9tude clinique aux USA, Hemerion a obtenu l\u2019autorisation de l\u2019ANSM (Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9) pour ouvrir un nouveau centre d\u2019essai au CHU de Lille en juillet 2025.Cette ouverture confirme la capacit\u00e9 d\u2019Hemerion \u00e0 travailler efficacement avec les autorit\u00e9s sanitaires de ... Lire plus\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hemerion.com\/fr\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\/\" \/>\n<meta property=\"og:site_name\" content=\"Hemerion\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-18T17:00:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-18T17:00:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/hemerion.com\/wp-content\/uploads\/hemerion-heliance-packaging.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t<meta property=\"og:image:height\" content=\"1328\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dominique Maeker\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HemerionTx\" \/>\n<meta name=\"twitter:site\" content=\"@HemerionTx\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dominique Maeker\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\\\/\"},\"author\":{\"name\":\"Dominique Maeker\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#\\\/schema\\\/person\\\/0d627e77d4bfc450cd055bf3010b65d5\"},\"headline\":\"Hemerion ouvre un nouveau site d\u2019investigation en Europe et acc\u00e9l\u00e8re le d\u00e9veloppement clinique de la th\u00e9rapie combin\u00e9e Pentalafen \\\/ Heliance\",\"datePublished\":\"2025-11-18T17:00:32+00:00\",\"dateModified\":\"2025-11-18T17:00:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\\\/\"},\"wordCount\":324,\"publisher\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/hemerion-heliance-packaging.jpg?fit=2000%2C1328&ssl=1\",\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\\\/\",\"url\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\\\/\",\"name\":\"Hemerion ouvre un nouveau site d\u2019investigation en Europe et acc\u00e9l\u00e8re le d\u00e9veloppement clinique de la th\u00e9rapie combin\u00e9e Pentalafen \\\/ Heliance - Hemerion\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/hemerion-heliance-packaging.jpg?fit=2000%2C1328&ssl=1\",\"datePublished\":\"2025-11-18T17:00:32+00:00\",\"dateModified\":\"2025-11-18T17:00:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/hemerion.com\\\/fr\\\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\\\/#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/hemerion-heliance-packaging.jpg?fit=2000%2C1328&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/hemerion-heliance-packaging.jpg?fit=2000%2C1328&ssl=1\",\"width\":2000,\"height\":1328,\"caption\":\"Gros plan sur la bo\u00eete du dispositiof Heliance dans un bloc op\u00e9ratoire\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hemerion ouvre un nouveau site d\u2019investigation en Europe et acc\u00e9l\u00e8re le d\u00e9veloppement clinique de la th\u00e9rapie combin\u00e9e Pentalafen \\\/ Heliance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/\",\"name\":\"Hemerion\",\"description\":\"Advancing cancer therapies at the speed of light\",\"publisher\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#organization\",\"name\":\"Hemerion\",\"url\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/hemerion-logo.png?fit=1581%2C460&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/hemerion-logo.png?fit=1581%2C460&ssl=1\",\"width\":1581,\"height\":460,\"caption\":\"Hemerion\"},\"image\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/HemerionTx\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/hemerion-therapeutics\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCWwcUj-aSdo32OYwN5vjf8Q\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#\\\/schema\\\/person\\\/0d627e77d4bfc450cd055bf3010b65d5\",\"name\":\"Dominique Maeker\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e7c6eba69bd9b57ed819d4a1bc57b9db9cb0b97bbcbeff06d7b640313bfbe3bf?s=96&d=identicon&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e7c6eba69bd9b57ed819d4a1bc57b9db9cb0b97bbcbeff06d7b640313bfbe3bf?s=96&d=identicon&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e7c6eba69bd9b57ed819d4a1bc57b9db9cb0b97bbcbeff06d7b640313bfbe3bf?s=96&d=identicon&r=g\",\"caption\":\"Dominique Maeker\"},\"url\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/author\\\/dominiquemaeker0240\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hemerion ouvre un nouveau site d\u2019investigation en Europe et acc\u00e9l\u00e8re le d\u00e9veloppement clinique de la th\u00e9rapie combin\u00e9e Pentalafen \/ Heliance - Hemerion","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hemerion.com\/fr\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\/","og_locale":"fr_FR","og_type":"article","og_title":"Hemerion ouvre un nouveau site d\u2019investigation en Europe et acc\u00e9l\u00e8re le d\u00e9veloppement clinique de la th\u00e9rapie combin\u00e9e Pentalafen \/ Heliance - Hemerion","og_description":"A la suite du lancement de sa derni\u00e8re \u00e9tude clinique aux USA, Hemerion a obtenu l\u2019autorisation de l\u2019ANSM (Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9) pour ouvrir un nouveau centre d\u2019essai au CHU de Lille en juillet 2025.Cette ouverture confirme la capacit\u00e9 d\u2019Hemerion \u00e0 travailler efficacement avec les autorit\u00e9s sanitaires de ... Lire plus","og_url":"https:\/\/hemerion.com\/fr\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\/","og_site_name":"Hemerion","article_published_time":"2025-11-18T17:00:32+00:00","article_modified_time":"2025-11-18T17:00:37+00:00","og_image":[{"width":2000,"height":1328,"url":"https:\/\/hemerion.com\/wp-content\/uploads\/hemerion-heliance-packaging.jpg","type":"image\/jpeg"}],"author":"Dominique Maeker","twitter_card":"summary_large_image","twitter_creator":"@HemerionTx","twitter_site":"@HemerionTx","twitter_misc":{"\u00c9crit par":"Dominique Maeker","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/hemerion.com\/fr\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\/#article","isPartOf":{"@id":"https:\/\/hemerion.com\/fr\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\/"},"author":{"name":"Dominique Maeker","@id":"https:\/\/hemerion.com\/fr\/#\/schema\/person\/0d627e77d4bfc450cd055bf3010b65d5"},"headline":"Hemerion ouvre un nouveau site d\u2019investigation en Europe et acc\u00e9l\u00e8re le d\u00e9veloppement clinique de la th\u00e9rapie combin\u00e9e Pentalafen \/ Heliance","datePublished":"2025-11-18T17:00:32+00:00","dateModified":"2025-11-18T17:00:37+00:00","mainEntityOfPage":{"@id":"https:\/\/hemerion.com\/fr\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\/"},"wordCount":324,"publisher":{"@id":"https:\/\/hemerion.com\/fr\/#organization"},"image":{"@id":"https:\/\/hemerion.com\/fr\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/hemerion-heliance-packaging.jpg?fit=2000%2C1328&ssl=1","articleSection":["Actualit\u00e9s"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/hemerion.com\/fr\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\/","url":"https:\/\/hemerion.com\/fr\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\/","name":"Hemerion ouvre un nouveau site d\u2019investigation en Europe et acc\u00e9l\u00e8re le d\u00e9veloppement clinique de la th\u00e9rapie combin\u00e9e Pentalafen \/ Heliance - Hemerion","isPartOf":{"@id":"https:\/\/hemerion.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/hemerion.com\/fr\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\/#primaryimage"},"image":{"@id":"https:\/\/hemerion.com\/fr\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/hemerion-heliance-packaging.jpg?fit=2000%2C1328&ssl=1","datePublished":"2025-11-18T17:00:32+00:00","dateModified":"2025-11-18T17:00:37+00:00","breadcrumb":{"@id":"https:\/\/hemerion.com\/fr\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hemerion.com\/fr\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/hemerion.com\/fr\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\/#primaryimage","url":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/hemerion-heliance-packaging.jpg?fit=2000%2C1328&ssl=1","contentUrl":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/hemerion-heliance-packaging.jpg?fit=2000%2C1328&ssl=1","width":2000,"height":1328,"caption":"Gros plan sur la bo\u00eete du dispositiof Heliance dans un bloc op\u00e9ratoire"},{"@type":"BreadcrumbList","@id":"https:\/\/hemerion.com\/fr\/hemerion-ouvre-un-nouveau-site-dinvestigation-en-europe-et-accelere-le-developpement-clinique-de-la-therapie-combinee-pentalafen-heliance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/hemerion.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Hemerion ouvre un nouveau site d\u2019investigation en Europe et acc\u00e9l\u00e8re le d\u00e9veloppement clinique de la th\u00e9rapie combin\u00e9e Pentalafen \/ Heliance"}]},{"@type":"WebSite","@id":"https:\/\/hemerion.com\/fr\/#website","url":"https:\/\/hemerion.com\/fr\/","name":"Hemerion","description":"Advancing cancer therapies at the speed of light","publisher":{"@id":"https:\/\/hemerion.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hemerion.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/hemerion.com\/fr\/#organization","name":"Hemerion","url":"https:\/\/hemerion.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/hemerion.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/hemerion-logo.png?fit=1581%2C460&ssl=1","contentUrl":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/hemerion-logo.png?fit=1581%2C460&ssl=1","width":1581,"height":460,"caption":"Hemerion"},"image":{"@id":"https:\/\/hemerion.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/HemerionTx","https:\/\/www.linkedin.com\/company\/hemerion-therapeutics\/","https:\/\/www.youtube.com\/channel\/UCWwcUj-aSdo32OYwN5vjf8Q"]},{"@type":"Person","@id":"https:\/\/hemerion.com\/fr\/#\/schema\/person\/0d627e77d4bfc450cd055bf3010b65d5","name":"Dominique Maeker","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/e7c6eba69bd9b57ed819d4a1bc57b9db9cb0b97bbcbeff06d7b640313bfbe3bf?s=96&d=identicon&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e7c6eba69bd9b57ed819d4a1bc57b9db9cb0b97bbcbeff06d7b640313bfbe3bf?s=96&d=identicon&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e7c6eba69bd9b57ed819d4a1bc57b9db9cb0b97bbcbeff06d7b640313bfbe3bf?s=96&d=identicon&r=g","caption":"Dominique Maeker"},"url":"https:\/\/hemerion.com\/fr\/author\/dominiquemaeker0240\/"}]}},"jetpack_featured_media_url":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/hemerion-heliance-packaging.jpg?fit=2000%2C1328&ssl=1","jetpack_shortlink":"https:\/\/wp.me\/pd9WhZ-2cz","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/posts\/8467","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/users\/207845439"}],"replies":[{"embeddable":true,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/comments?post=8467"}],"version-history":[{"count":1,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/posts\/8467\/revisions"}],"predecessor-version":[{"id":8468,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/posts\/8467\/revisions\/8468"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/media\/8466"}],"wp:attachment":[{"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/media?parent=8467"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/categories?post=8467"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/tags?post=8467"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}